TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
XFOR

X4 Pharmaceuticals Inc

Healthcare · Biotechnology

2.90$ +0.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

X4 Pharmaceuticals Inc (XFOR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -86 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow XFOR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-11 -22 -28 -25 -48 -59 -71 -77 -97 -131 -86
0.4 0.3 0.2 0.1 0.1 1.2 1.9 0.5 0.4 0.8 1.3
0.1 0.6 0.9 5.6 2.1 5.4 6.2 5.2 8.7 8.2 4.3
– 0.5 -0.2 4.5 7.2 6.5 19 6.2 – – –
1.4 -0.5 3.4 3.1 -3.2 -4.1 -1.5 5.7 0.3 2.7 -2.6
0.2 0.1 0.0 0.0 0.2 1.4 0.6 0.1 0.1 7.3 3.0
-0.2 -0.1 0.0 0.0 27 -1.4 -0.6 -0.1 -15 67 8.2
– – 46 – 20 12 14 0.0 – – –
0.0 -0.1 -0.2 -1.1 20 -0.3 -2.0 0.0 0.0 – –
– 6.0 6.0 3.5 0.5 12 0.0 -0.8 20 20 0.0
12 18 101 6.9 141 12 74 117 89 20 239
6.8 -3.7 74 -69 120 -47 2.8 40 -23 -44 161
-11 -22 -28 -25 -48 -60 -72 -77 -97 -138 -89

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?